Walgreens Study of Hematological Oral Oncolytics Reinforces Importance of Adherence
October 23, 2024
October 23, 2024
DEERFIELD, Illinois, Oct. 23 (TNSres) -- Walgreens Boots Alliance, a pharmacy-led, health and wellbeing enterprise company, issued the following news release:
* * *
Findings revealed fewer hospital stays and cost savings among adherent patients.
* * *
A recent study evaluating the use of hematological oral oncolytics in cancer patients demonstrated that patients who were adherent to their oral cancer medications were more likely to have fewer h . . .
* * *
Findings revealed fewer hospital stays and cost savings among adherent patients.
* * *
A recent study evaluating the use of hematological oral oncolytics in cancer patients demonstrated that patients who were adherent to their oral cancer medications were more likely to have fewer h . . .